YNBY International Ltd. (0030.HK)
Hong Kong, HK
YNBY International Ltd. operates as an investment holding company, conducting business primarily in money lending and the global trade of various goods and commodities across Hong Kong, the People's Republic of China, and international territories. The firm's operations are divided into distinct segments: Money Lending, Trading of Goods and Commodities, and Cannabidiol (CBD) isolate. In its financial services arm, the company offers short-term loans to both private individuals and corporate entities. Its trading activities encompass a diverse portfolio, including refined edible oil, sugar, cosmetics, cannabidiol, and personal care products. Moreover, YNBY International has established a strategic partnership with Alpex Pharma SA to jointly advance the development and commercialization of nutraceuticals. Located in Wan Chai, Hong Kong, the company adopted its current name after previously operating as ABC Communications (Holdings) Limited and subsequently as Ban Loong Holdings Limited, a change that occurred in October 2015.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +7.11% | -6.22% | -13.88% | -27.24% | -12.08% | -13.52% | +8.21% | -15.26% | -54.62% | +110.91% | -89.05% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Investment - Banking & Investment Services: +23.9%+46.8% ★ Q4'25: +410.0% (vs Q3'22)
-
EPS growth Investment - Banking & Investment Services: +31.6%-78.3% Q4'25: +100.9% (vs Q3'22)
-
FCF margin FCF growth · Investment - Banking & Investment Services: +22.1%-9.9% Q4'25: -13.2% (vs Q3'22)
-
EBIT margin Investment - Banking & Investment Services: +33.7%+0.7% Q4'25: +0.6% (vs Q3'22)
-
ROIC Investment - Banking & Investment Services: +2.7%+2.9% ★ Q4'25: +6.1% (vs Q3'22)
-
Share dilution Investment - Banking & Investment Services: +0.1%+5.6% Q4'25: +43.0% (vs Q3'22)
-
Debt / EBITDA Net debt/EBITDA · Investment - Banking & Investment Services: -0.48×0.63× ★ Q4'25: 0.43× (vs Q3'22)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 1/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-28 | C | 2/5 | 1/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 2/5 | 2/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-15 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 2/5 | 3/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 2/5 | 2/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 2/5 | 2/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 2/5 | 2/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 1/5 | 1/5 | 2/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 2/5 | 3/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 2/5 | 4/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ming Tang | Chief Executive Officer & Executive Director | 4M | male |
| Huaiyu Liu | Chief Financial Officer, Executive Director & Company Secretary | 692.6K | male |
| Ming Dong | Executive Chairman of the Board | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 0030.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
